Preparation of Acid‐Resistant Microcapsules with Shell‐Matrix Structure to Enhance Stability of Streptococcus Thermophilus IFFI 6038

Abstract Microencapsulation is an effective technology used to protect probiotics against harsh conditions. Extrusion is a commonly used microencapsulation method utilized to prepare probiotics microcapsules that is regarded as economical and simple to operate. This research aims to prepare acid‐resistant probiotic microcapsules with high viability after freeze‐drying and optimized storage stability. Streptococcus thermophilus IFFI 6038 (IFFI 6038) cells were mixed with trehalose and alginate to fabricate microcapsules using extrusion. These capsules were subsequently coated with chitosan to obtain chitosan‐trehalose‐alginate microcapsules with shell‐matrix structure. Chitosan‐alginate microcapsules (without trehalose) were also prepared using the same method. The characteristics of the microcapsules were observed by measuring the freeze‐dried viability, acid resistance, and long‐term storage stability of the cells. The viable count of IFFI 6038 in the chitosan‐trehalose‐alginate microcapsules was 8.34 ± 0.30 log CFU g −1 after freeze‐drying (lyophilization), which was nearly 1 log units g −1 greater than the chitosan‐alginate microcapsules. The viability of IFFI 6038 in the chitosan‐trehalose‐alginate microcapsules was 6.45 ± 0.09 log CFU g −1 after 120 min of treatment in simulated gastric juices, while the chitosan‐alginate microcapsules only measured 4.82 ± 0.22 log CFU g −1 . The results of the long‐term storage stability assay indicated that the viability of IFFI 6038 in chitosan‐trehalose‐alginate microcapsules was higher than in chitosan‐alginate microcapsules after storage at 25 °C. Trehalose played an important role in the stability of IFFI 6038 during storage. The novel shell‐matrix chitosan‐trehalose‐alginate microcapsules showed optimal stability and acid resistance, demonstrating their potential as a delivery vehicle to transport probiotics.